title: Validated Stability-indicating Reverse-phase Ultra-performance Liquid Chromatography Method for Simultaneous Determination of Sodium Methylparaben, Sodium Propylparaben and Ketorolac Tromethamine in Topical Dosage Forms.
abstract: A sensitive, fast, and stability-indicating isocratic reverse-phase ultra-performance liquid chromatography method was developed and validated for quantitative simultaneous determination of sodium methylparaben, sodium propylparaben and ketorolac tromethamine in topical dosage forms. Separation of all peaks was achieved by using acquity ethylene bridged hybrid C18 (50×2.1 mm, 1.7 μ) as stationary phase, mobile phase used was triethylamine buffer (pH 2.5):tetrahydrofuran:methanol (665:35:300, v/v/v) with isocratic mode at a flow rate of 0.40 ml/min. All component were detected at 252 nm with 10 min run time. The described method was found to be linear in the concentration range of 248-744 μg/ml for ketorolac tromethamine, 20.8-62.4 μg/ml for sodium methylparaben and 2.38-7.13 μg/ml for sodium propylparaben with correlation coefficients more than 0.999. Method was validated in terms of specificity, linearity, accuracy, precision, solution stability, filter equivalency, and robustness as per International Conference on Harmonization guideline. Formulation was exposed to the stress conditions of peroxide, acid, base, thermal, and photolytic degradation and proven all components were well separated in the presence of degradants.
authors.affiliation: Department of Chemistry, National Institute of Technology, Durgapur-713 209, India.
authors.forename: C
authors.initials: C
authors.lastname: Roy
authors.forename: J
authors.initials: J
authors.lastname: Chakrabarty
authors.forename: P B
authors.initials: PB
authors.lastname: Modi
keywords: Ketorolac tromethamine; sodium methylparaben; sodium propylparaben; ultra-performance liquid chromatography
references.citation: Chirality. 1993;5(1):31-5
references.pmid: 8448075
references.citation: J Chromatogr B Biomed Appl. 1994 Aug 5;658(1):177-82
references.pmid: 7952121
references.citation: Pharm Res. 1995 Nov;12(11):1652-7
references.pmid: 8592665
references.citation: J Anal Toxicol. 1995 Mar-Apr;19(2):61-4
references.pmid: 7769787
references.citation: Pharm Res. 1989 Jan;6(1):62-5
references.pmid: 2717521
references.citation: J Pain Palliat Care Pharmacother. 2009;23(1):26-34
references.pmid: 19296352
references.citation: J Chromatogr. 1993 Apr 21;614(1):180-4
references.pmid: 8496281
references.citation: J Pharm Biomed Anal. 1994 Mar;12(3):343-6
references.pmid: 8031933
references.citation: Chem Cent J. 2012 Sep 04;6(1):94
references.pmid: 22947049
references.citation: J Chromatogr A. 2009 May 1;1216(18):3851-6
references.pmid: 19281996
references.citation: J Chromatogr. 1990 Dec 14;534:241-6
references.pmid: 2094713